In particular, CD4+ T cells release tumor necrosis factor beta (TNFβ) which binds to its CD8+ T cell receptor (TNFR2) in the same manner, but with the opposite outcome, that tumor cells release immune checkpoints that bind to their CD8+ T cell receptors, e.g. PD-1 (12). This evidence concerns the gene LTA and neoplasm.